Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
accelEQ
AddedFeb 15, 2024
UpdatedJun 18, 2026
accelEQ

accelEQ

Seed

AccelEQ: A digital health tech firm enhancing patient care and provider efficiency via AI, based in Tampa, FL.

HQ
Tampa, FL, US
Founded
2019
Accelerator
Techstars logoTechstars: Miami2023
Overview
Compare
Fundraising
Employees
Website

Founded in 2019 and headquartered in Tampa, Florida, AccelEQ is a digital health company committed to enhancing patient care and provider efficiency through advanced machine learning and artificial intelligence solutions. Their core mission is to optimize the clinical workflow and improve patient outcomes by automating medical documentation and data analysis. AccelEQ offers a virtual care platform that includes automated point-of-care transcription, medical data extraction, and AI-driven medical data analysis, targeting healthcare providers who seek to eliminate wasted time and increase revenue.

AccelEQ has garnered attention for its innovative approach to solving critical issues in healthcare, such as revenue cycle integrity and provider burnout. The company has attracted notable investors and healthcare professionals who support its mission to transform clinical operations. Key achievements include the successful implementation of their platform in various healthcare settings, leading to measurable improvements in efficiency and patient care quality. Overall, AccelEQ's impact on the healthcare industry is significant, as it continues to drive advancements in digital health technology.

accelEQ - Similar Companies

Wellacy Health logo

Wellacy Health

bewellacy.com

Medgeo logo

Medgeo

medgeo.com

HealthBridgeHQ logo

HealthBridgeHQ

healthbridgehq.com

CuraPatient logo

CuraPatient

curapatient.com

AI Success Parnters logo

AI Success Parnters

Accelera Innovations logo

Accelera Innovations

Clearstep logo

Clearstep

clearstep.health

Acclinate logo

Acclinate

acclinate.com

Equani logo

Equani

Curai logo

Curai

curai.com

Sopris Health logo

Sopris Health

soprishealth.com

Aiva logo

Aiva

aiva.ai

care.ai logo

care.ai

care.ai

RapidAI logo

RapidAI

rapidai.com

Arintra logo

Arintra

arintra.com

accelEQ - Quick Facts

Who are accelEQ's competitors?

Companies similar to accelEQ include Wellacy Health, Medgeo, HealthBridgeHQ and CuraPatient.

When was accelEQ founded?

accelEQ was founded in 2019.

Where is accelEQ's headquarters located?

accelEQ's headquarters is located in Tampa, FL, US.

When was accelEQ's last funding round?

accelEQ's most recent funding round was for $120k (USD) in September 2023.

How much has accelEQ raised to-date?

As of Sep 12, 2023, accelEQ has raised a total of $330k (USD).

How many employees does accelEQ have?

accelEQ has 15 employees as of Feb 4, 2024.

accelEQ - Classification

Ownership
  • Private
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software